Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 24.65

+1.5%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Platter who wrote (1660)	4/22/2000 11:52:00 PM
From: Ron	of 1722

Jerry Dodson, manager of the Parnassus Fund, notes Schering Plough (SGP 40 1/8) is trading at "bargain levels" because of concerns about its drug, Claritin, which is due to go off patent in the near future. Dodson adds that Schering should come out with a new drug similar to Claritin, which should keep earnings stable. "Schering's stock is a bargain below $40." From the Internet Financial Report...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next